Vericel (VCEL) Short term Debt (2010 - 2018)
Vericel's (VCEL) quarterly Short term Debt came in at $4.1 million in Q3 2018, up 60.23% year-over-year from $2.6 million in Q3 2017, and up 43.86% quarter-over-quarter from $2.8 million in Q2 2018.
Analysis
Vericel (VCEL) Short term Debt (2010 - 2018) Analysis & Trends
Vericel has disclosed Short term Debt across 8 years of filings, most recently posting $4.1 million for Q3 2018.
- In Q3 2018, Short term Debt rose 60.23% year-over-year to $4.1 million; the TTM figure through Sep 2018 stood at $4.1 million (up 60.23% YoY), while the FY2017 annual figure was $350000.0, down 55.07% from the prior year.
- Short term Debt came in at $4.1 million for Q3 2018 at Vericel, up from $2.8 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $5.6 million in Q3 2016 to a low of $2000.0 in Q1 2014.
- Average Short term Debt over 4 years is $2.0 million, with a median of $1.6 million recorded in 2014.
- The largest YoY upside for Short term Debt was 15900.0% in 2014 against a maximum downside of 92.59% in 2014.
- Over 4 years, Short term Debt stood at $348000.0 in 2014, then surged by 123.85% to $779000.0 in 2016, then plunged by 55.07% to $350000.0 in 2017, then soared by 1070.57% to $4.1 million in 2018.
- Per Business Quant data, the three most recent Short term Debt figures were $4.1 million in Q3 2018, $2.8 million in Q2 2018, and $1.6 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 4.10 Mn |
| Jun 30, 2018 | 2.85 Mn |
| Mar 31, 2018 | 1.60 Mn |
| Dec 31, 2017 | 350,000.00 |
| Sep 30, 2017 | 2.56 Mn |
| Jun 30, 2017 | 2.11 Mn |
| Mar 31, 2017 | 1.45 Mn |
| Dec 31, 2016 | 779,000.00 |
| Sep 30, 2016 | 5.57 Mn |
| Dec 31, 2014 | 348,000.00 |
| Sep 30, 2014 | 1.60 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Mar 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Jun 30, 2013 | 19,000.00 |
| Mar 31, 2013 | 27,000.00 |
| Dec 31, 2012 | 34,000.00 |
| Sep 30, 2012 | 40,000.00 |
| Jun 30, 2012 | 40,000.00 |